Clinical Trial Update: Aspirin in Patients With Myocardial Infarction and Thrombocytopenia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aspirin in patients with myocardial infarction and thrombocytopenia was terminated, and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Thrombocytopenia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Thrombocytopenia, Myocardial Infarction | Phase 3 | Status: TERMINATED | Results posted: 2010-10-13